Alligator Bioscience AB (publ) (STO:ATORX)

Alligator Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	112	189	453	342	567	568
Market Cap Growth	-11.63%	-58.27%	32.59%	-39.69%	-0.11%	-24.72%
Enterprise Value	124	151	348	213	499	443
Last Close Price	0.21	249.00	689.00	1550.00	2570.00	6985.35
PS Ratio	2.43	3.28	7.65	9.50	42.54	102.91
PB Ratio	-12.14	-1.45	38.24	3.84	2.01	4.93
P/TBV Ratio	-	-	-	4.81	2.15	5.86
EV/Sales Ratio	2.69	2.62	5.87	5.93	37.45	80.38
Debt / Equity Ratio	-4.02	-0.33	1.36	0.28	0.03	0.11
Asset Turnover	0.55	0.52	0.41	0.14	0.06	0.02
Quick Ratio	0.51	0.35	0.76	1.79	6.21	3.56
Current Ratio	0.56	0.35	0.79	1.90	6.32	3.59
Return on Equity (ROE)	-	-	-492.71%	-104.17%	-71.31%	-76.68%
Return on Assets (ROA)	-114.73%	-128.22%	-108.23%	-47.81%	-36.50%	-38.88%
Return on Capital Employed (ROCE)	-834.60%	235.30%	-1287.40%	-183.00%	-49.60%	-118.80%
Earnings Yield	-69.24%	-123.64%	-54.84%	-56.57%	-25.00%	-25.25%
FCF Yield	-147.15%	-112.29%	-42.30%	-50.61%	-22.42%	-24.92%
Buyback Yield / Dilution	-2322.13%	-63.72%	-103.32%	-146.00%	-25.61%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.